Module 4: Hip and Pelvis
The Prolotherapy Hip and Pelvis module is designed and presented to give you the in-depth knowledge you need to understand shoulder anatomy, take a detailed history, do a thorough and directed physical exam, create your differential diagnosis, landmark target areas, understand the injection and needle-handling techniques, and consider rehabilitation.
Dr. Ravin brings to bear his considerable experience in successfully treating thousands of patients, combining instruction with graphics, animations, slides, links, and other media to enable you to learn the skills necessary to treat patients with hip and pelvis pain.
CME Credits: 3.25
- Pain Diagram
- Physical Examination
- Differential Diagnosis
- Landmark Identification
- Injections and Needle-handling
The power of getting to the point is that in many instances, you will be treating a very small area that’s been injured. This module shows you how to consistently get your needle to the injured site–quickly, accurately, and effectively.
It is essential to gather these fundamental skills, which include the scientific background for how it works, the ability to take good histories, administer directed physical examinations, derive a good differential diagnosis, and identify and spot landmarks.
All of these are techniques that you will learn throughout this course.
Dr. Thomas Ravin, M.D. has been a practicing prolotherapist for nearly 30 years, and has been teaching prolotherapy to medical professionals since the early 1990’s. Dr. Ravin has trained hundreds of professionals, using the experience he has gained from successfully treating thousands of patients. Dr. Ravin’s text, Principles of Prolotherapy, written with Dr. Mark S. Cantieri, D.O. and Dr. George J. Pasquarello, D.O., is a best-seller, and is widely considered to be the most comprehensive text covering all aspects of prolotherapy.
Prolotherapy: Getting to the Point – Course Work CME Credits and Information
Jointly provided by Postgraduate Institute for Medicine and the American Academy of Musculoskeletal Medicine
Release Date: March 14, 2015
Expiration Date: March 31, 2016
Estimated time to complete activity:
- Module 4: Hip and Pelvis – 3.25 Hours
Notice as to the type of hardware and software needed to participate in the activity:
Prolotherapy: Getting to the Point and ProlotherapyEducation.com support most devices with access to the Internet, including PCs, Laptops, mobile devices, and tablets. A connection to the Internet is required.
Mechanism for the learner to contact PIM: www.pimed.com
This activity has been designed to meet the educational needs of Physiatrists, Pain Management Physicians, Sports Medicine Physicians, Orthopedic Medicine Physicians, Family Practice Physicians, Osteopathic Manipulative Medicine Physicians, Naturopaths, PAs, Nurse Practitioners involved in the care of patients with ligament laxity, joint dysfunctions, tendinosis, muscle spasms, scars, and related pain.
After completing this activity, the participant should be better able to:
Module 4: Hip and Pelvis
- Understand the relevant anatomy of the hip and pelvis.
- Understand and be able to apply taking a relevant history of the hip and pelvis.
- Understand the relevance of the pain diagram as it relates to the hip and pelvis, and be able to apply pain diagram findings to the patient’s differential diagnosis.
- Understand and be able to administer a physical examination of the hip and pelvis as it applies to relevant treatment.
- Derive a differential diagnosis for treatment from the information gathered in the anatomy, history, pain diagram, and physical exam.
- Identify and draw landmarks, using knowledge from previous phases and palpation as precursors to injection.
- Understand how to use landmarks to determine injection points.
- Understand needle-handling skills that will be necessary in “getting to the point” of treatment.
Dr. Thomas Ravin, M.D.
- American Association of Orthopedic Medicine
- American Board of Nuclear Medicine
- American Board of Radiology
- Recipient of AAOM’s Lifetime Achievement Award, 2012
- Patients’ Choice Award, 2014
- On-time Doctor Award, 2014
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and the American Academy of Musculoskeletal Medicine. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of the following AMA PRA Category 1 Credit(s)™:
Module 4: Hip and Pelvis – 3.25 Credit Hours
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest:
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty: Reported Financial Relationship:
Tom Ravin, M.D. Has no real or apparent conflicts of interest to report
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Method of Participation and Request for Credit:
During the period March 16, 2015 through March 31, 2016, participants must read the learning objectives and faculty disclosures and study the educational activity.
PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID:
Module 4: Hip and Pelvis – Course ID provided upon successfully passing 15-question assessment
Upon registering and successfully completing the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.